HNRNPA1 and skin cancer: In summary, the estradiol is a rationally anti-skin cancer agent that induces MDM2 down-regulation via enhanced hnRNPA1 expression, and controls the oncogenic activities of MDM2 in melanomas in vitro/vivo testing.